HEMATOLOGIC MALIGNANCY
Clinical trials for HEMATOLOGIC MALIGNANCY explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGIC MALIGNANCY trials appear
Sign up with your email to follow new studies for HEMATOLOGIC MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kids: drug combo aims to prevent transplant complications
Disease control TerminatedThis study looked at a new way to prevent severe graft-versus-host disease (GVHD) in children who had a bone marrow transplant for blood cancers. The goal was to see if stopping certain immune-suppressing drugs after day 60 could lower the risk of severe GVHD. Only 3 children too…
Matched conditions: HEMATOLOGIC MALIGNANCY
Phase: PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated May 26, 2026 04:00 UTC
-
Radiation boost for CAR t fails to launch: pilot study terminated
Disease control TerminatedThis small pilot study tested whether adding radiation therapy could help CAR T-cell treatment work better in people with lymphoma that did not respond to CAR T alone. Only 3 participants were enrolled before the study was stopped early. The main goal was to check safety and side…
Matched conditions: HEMATOLOGIC MALIGNANCY
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New antibiotic tackles tough infections in vulnerable cancer patients
Disease control TerminatedThis study tested the antibiotic ceftolozane-tazobactam in 17 people with blood cancers or who had a stem cell transplant and developed a serious Pseudomonas infection. The goal was to see if the drug could help patients survive and clear the infection within 30 days. Participant…
Matched conditions: HEMATOLOGIC MALIGNANCY
Phase: PHASE4 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
New drug BR108 tested in blood cancer patients – early results expected
Disease control TerminatedThis early-stage study tested a new drug called BR108 in 8 adults with advanced blood cancers (lymphoma, leukemia, or myelodysplastic syndrome) that had not responded to other treatments. The main goals were to check safety, find the right dose, and see if the drug could shrink t…
Matched conditions: HEMATOLOGIC MALIGNANCY
Phase: PHASE1 • Sponsor: BioRay Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 01, 2026 15:59 UTC
-
PET scan may spot silent heart danger in cancer patients
Diagnosis TerminatedThis small pilot study tested whether a special PET scan could detect early, symptom-free heart inflammation caused by immune checkpoint inhibitor cancer drugs. Only 2 people took part before the study ended. The goal was to see if this imaging method could identify hidden heart …
Matched conditions: HEMATOLOGIC MALIGNANCY
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated May 26, 2026 03:53 UTC